Massive Bio
AI powered oncology platform that connects patients to clinical trials while enabling pharma to get access to patients.
Launch date
Employees
Market cap
-
Enterprise valuation
$66—99m (Dealroom.co estimates Dec 2022.)
New York City New York (HQ)
Financials
Estimates*
| USD | 2020 | 2021 | 2023 |
|---|---|---|---|
| Revenues | 1.5m | 2.7m | 8.3m |
| % growth | - | 80 % | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Convertible | ||
N/A | Seed | ||
N/A | Early VC | ||
N/A | Seed | ||
$2.6m | Seed | ||
* | $9.0m | Early VC | |
* | $16.5m | Series B | |
| Total Funding | $28.1m | ||
Recent News about Massive Bio
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.